Skip to main content

Table 1 Clinical characters, risk factor and symptoms of the cohort

From: Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction

Clinicopathological features

All cohort (n = 186)

AMI cases

P

Yes (n = 76)

No (n = 110)

Age (year)

62.2 (46–88)

64.6 (46–88)

60 (52–81)

0.071

Male

104

43

61

0.282

BMI

27.2 (23–34)

26.9 (24–34)

27.5 (23–32)

0.455

STEMI

 

25

  

NSTEMI

 

51

  

Disease and personal history

Hypertension

122

74

48

0.341

Hypercholesterolemia

104

54

50

0.033

Diabetes

88

43

45

0.237

Smoking

104

42

62

0.569

Alcohol drinking

92

36

56

0.382

Previous AMI

34

19

15

0.020

Previous PTCA

25

15

10

0.001

Physical examination

Systolic blood pressure, mmHg

138 (121–185)

139 (121–179)

141 (127–185)

0.875

Diastolic blood pressure, mmHg

83 (72–103)

83 (75–99)

84 (72–103)

0.531

Heart rate – beats per minute

75 (62–145)

79 (67–145)

73 (62–91)

0.129

Electrocardiographic findings

T-wave inversion

25

21

4

< 0.001

ST-segment change

46

36

10

< 0.001

Other Changes

18

9

9

< 0.001

No significant changes

97

10

87

< 0.001

  1. BMI: body mass index; AMI: acute myocardial infarction; STEMI: ST-segment-elevation; NSTEMI: non-ST-segment elevation; PTCA, Percutaneous transluminal coronary angioplasty.
  2. The results with a significant difference were marked in bold.